ABBV

HOLD

AbbVie Inc.

Healthcare · Rank #33 · Analyzed Apr 20, 2026

$208.38

Current Price

$531.69

Intrinsic Value

0.0%

Upside/Downside

10/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score3.5/5.0

Framework RatingHOLD

Price vs Intrinsic ValueOvervalued by 0.0%

Fair Value Range

Low$47.78

Base (IV)$531.69

High$827.14

Entry Points

Conservative$47.78

Moderate$289.74

Aggressive$531.69

⚠️ Warnings

Upside capped: raw 297% exceeds 200% — valuation unreliable

Quality & Moat Breakdown

Return on Equity6225.0% → 1.0/1.0

Debt LevelD/E 100 → 0/1.0

Revenue QualityGrowth 7.7%, margin Δ+2.7% +recovery → 1.0/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins6.9% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.